5 Sector ETFs That Crushed The Market In July
- Analysis
- Zacks Investment Research
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
XTL Biopharmaceuticals Ltd (XTLB)
XTL Biopharmaceuticals Ltd stock price live, this page displays TASE XTLB stock exchange data. View the XTLB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the XTL Biopharmaceuticals Ltd real time stock price chart below.
What Is the XTL Biopharmaceuticals Ltd Stock Price Today?
The XTL Biopharmaceuticals Ltd stock price today is 5.2.
What Is the Stock Symbol for XTL Biopharmaceuticals Ltd?
The stock ticker symbol for XTL Biopharmaceuticals Ltd is XTLB.
Is XTLB the Same as $XTLB?
$XTLB is a common way to refer to the XTL Biopharmaceuticals Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does XTL Biopharmaceuticals Ltd Trade On?
XTL Biopharmaceuticals Ltd is listed and trades on the Tel Aviv stock exchange.
Is XTL Biopharmaceuticals Ltd a Good Stock to Buy?
Determining whether XTL Biopharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current XTL Biopharmaceuticals Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XTLB quote. (ISIN: IL0010854979)
What Is the XTL Biopharmaceuticals Ltd Stock Price Today?
The XTL Biopharmaceuticals Ltd stock price today is 5.2.
What Is the Stock Symbol for XTL Biopharmaceuticals Ltd?
The stock ticker symbol for XTL Biopharmaceuticals Ltd is XTLB.
Is XTLB the Same as $XTLB?
$XTLB is a common way to refer to the XTL Biopharmaceuticals Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does XTL Biopharmaceuticals Ltd Trade On?
XTL Biopharmaceuticals Ltd is listed and trades on the Tel Aviv stock exchange.
Is XTL Biopharmaceuticals Ltd a Good Stock to Buy?
Determining whether XTL Biopharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current XTL Biopharmaceuticals Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XTLB quote. (ISIN: IL0010854979)
5.2
0.0(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.9
5.4
52 wk Range
3.9
11.2
XTLB Scorecard
Full Analysis
Significant return over the last week
XTLB is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.95.4
52 wk Range
3.911.2
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
XTLB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Fed Holds Off Rate Hike For Now: Top 5 Gainers
- Analysis
- Zacks Investment Research
- 5 Sector ETFs That Crushed The Market In July
- Analysis
- Zacks Investment Research
- Fed Holds Off Rate Hike For Now: Top 5 Gainers
- Analysis
- Zacks Investment Research
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
XTL Biopharmaceuticals Ltd Company Profile
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren’s syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
Compare XTLB to Peers and Sector
Metrics to compare | XTLB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXTLBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.3x | −3.5x | −0.5x | |
PEG Ratio | −1.60 | −0.03 | 0.00 | |
Price / Book | 2.5x | 2.2x | 2.6x | |
Price / LTM Sales | 30.2x | 7.7x | 3.2x | |
Upside (Analyst Target) | - | 559.3% | 45.3% | |
Fair Value Upside | Unlock | 12.2% | 7.4% | Unlock |
Earnings
Latest Release
Apr 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
405.00K / --
FAQ
What Is the XTL Bio (XTLB) Stock Price Today?
The XTL Bio stock price today is 5.20
What Stock Exchange Does XTL Bio Trade On?
XTL Bio is listed and trades on the Tel Aviv Stock Exchange stock exchange.
What Is the Stock Symbol for XTL Bio?
The stock symbol for XTL Bio is "XTLB."
What Is the XTL Bio Market Cap?
As of today, XTL Bio market cap is 44.07M.
What Is XTL Bio's Earnings Per Share (TTM)?
The XTL Bio EPS (TTM) is -0.00.
From a Technical Analysis Perspective, Is XTLB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has XTL Bio Stock Split?
XTL Bio has split 1 times.
How Many Employees Does XTL Bio Have?
XTL Bio has 10 employees.
What is the current trading status of XTL Bio (XTLB)?
As of Jul 17, 2025, XTL Bio (XTLB) is trading at a price of 5.20, with a previous close of 5.20. The stock has fluctuated within a day range of 4.90 to 5.40, while its 52-week range spans from 3.90 to 11.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.